Hostname: page-component-76fb5796d-25wd4 Total loading time: 0 Render date: 2024-04-25T07:05:22.366Z Has data issue: false hasContentIssue false

Ethnic differences in CAPN10 SNP-19 in type 2 diabetes: a North-West Indian case control study and evidence from meta-analysis

Published online by Cambridge University Press:  15 January 2014

RUBINA SHARMA
Affiliation:
Department of Human Genetics, Guru Nanak Dev University, Amritsar 143005, Punjab, India
KAWALJIT MATHAROO
Affiliation:
Department of Human Genetics, Guru Nanak Dev University, Amritsar 143005, Punjab, India
ROHIT KAPOOR
Affiliation:
Heart Station and Diabetes Clinic, 2-Rani Ka Bagh, Amritsar 143001, Punjab, India
HIMANSHI CHOPRA
Affiliation:
International American University, Vieux fort, Saint Lucia, West Indies
AJS BHANWER*
Affiliation:
Department of Human Genetics, Guru Nanak Dev University, Amritsar 143005, Punjab, India
*
*Corresponding author: Department of Human Genetics, Guru Nanak Dev University, Amritsar, Punjab, India. Tel: +91-9814103474. Fax: +91-183-2258819, 2258820. E-mail: ajsbhanwer@gmail.com
Rights & Permissions [Opens in a new window]

Summary

Calpain 10 (CAPN10) variants have been associated with the genetic susceptibility to type 2 diabetes (T2D). In the present case-control study, we analysed the distribution of SNP-19 insertion/deletion (I/D) polymorphism in a total of 607 samples (103 T2D cases and 102 healthy controls) from Brahmin; (100 T2D cases and 100 healthy controls) from Bania and (100 T2D cases and 102 healthy controls) from Jat Sikh ethnic groups of the North-West Indian population. Increased frequency of I allele and II genotype was found in T2D in Brahmin ethnic group [P = 0·003, OR = 2·83 (1·43–5·61 at 95% CI)]. Significant correlation between II genotype and body mass index (BMI) was also observed [P = 0·003, OR = 3·31 (1·52–7·20 at 95% CI)]. No association for the genotypes and alleles was seen in Banias and Jat Sikhs. Our data suggests that SNP-19 I/D variation in the CAPN10 gene is modulated by ethnicity and influences the susceptibility to T2D in the North-West Indian population. We also performed a meta-analysis of relevant studies to assess the validity of this association. Data from 13 case-control studies with 15 760 samples comprising of 8395 T2D cases and 7365 controls were finally analysed. Significant heterogeneity between individual studies was evident in dominant and codominant models. The results of present meta-analysis indicate an association of T2D with carriers of DD genotype of CAPN10 I/D polymorphism. However, further analyses on a larger sample size are required to establish a conclusive association in meta-analysis.

Type
Research Paper
Copyright
Copyright © Cambridge University Press 2013 

1. Introduction

Type 2 diabetes (T2D) is a global public health crisis threatening all economies especially those of the developing countries (Hu, Reference Hu2011). It is characterized by three major metabolic abnormalities: impaired insulin-stimulated glucose uptake in muscle and fat, alterations in glucose-stimulated insulin secretion, and increased hepatic glucose production (American Diabetes Association, 2011). Estimates from the reports of International Diabetes Federation (IDF) predicted that by the year 2030, 552 million people will be suffering from T2D worldwide, and the projected figure for India is 101·2 million (International Diabetes Federation, 2011). The threat imposed by the escalating prevalence of the disease makes it a medical catastrophe of worldwide dimensions. T2D is a classic example of multifactorial disorder; its aetiology combines both genetic and environmental factors (Herder & Roden, Reference Herder and Roden2011). T2D is most often associated with older age, obesity, family history of diabetes, previous history of gestational diabetes, physical inactivity and certain ethnicities (Singh, Reference Singh2011). Keeping in view the prevalence and aetiology of the disease, it becomes imperative to define population specific genetic and environmental risk factors.

Calpains are a family of calcium-activated, neutral, non-lysosomal cysteine proteases. They have been proposed to be implicated in the regulation of a variety of cellular functions and may be responsible for adipocyte differentiation (Marshall et al., Reference Marshall, Hitman, Partridge, Clark, Ma, Shearer and Turner2005) as well as insulin-induced down-regulation of insulin receptor substrate-1, a key mediator of insulin action (Smith et al., Reference Smith, Rice and Garner1996). Calpain-10 is expressed in many important tissues in glucose metabolism, including pancreatic islets, skeletal muscle and liver, which suggested that it might affect insulin secretion, insulin action and hepatic glucose production (Horikawa et al., Reference Horikawa, Oda, Cox, Li, Orho-Melander, Hara, Hinokio, Lindner, Mashima, Schwarz, del Bosque-Plata, Horikawa, Oda, Yoshiuchi, Colilla, Polonsky, Wei, Concannon, Iwasaki, Schulze, Baier, Bogardus, Groop, Boerwinkle, Hanis and Bell2000). Genetic variants in the CAPN10 gene are associated with elevated free fatty acids and insulin resistance (Orho-Melander et al., Reference Orho-Melander, Klannemark, Svensson, Ridderstrale, Lindgren and Groop2002). CAPN10 is the first gene to be linked to T2D by positional cloning (Horikawa et al., Reference Horikawa, Oda, Cox, Li, Orho-Melander, Hara, Hinokio, Lindner, Mashima, Schwarz, del Bosque-Plata, Horikawa, Oda, Yoshiuchi, Colilla, Polonsky, Wei, Concannon, Iwasaki, Schulze, Baier, Bogardus, Groop, Boerwinkle, Hanis and Bell2000). Since then due to genetic heterogeneity, the role of CAPN10 has been examined in different ethnic groups with contradictory results (Cox et al., Reference Cox, Hayes, Roe, Tsuchiya and Bell2004). However, these results provide a tentative molecular mechanism to explain the association between variability in CAPN10 and T2D.

CAPN10 SNP-19 polymorphism is in the non-coding region and is believed to alter the risk by affecting its transcriptional regulation (Horikawa et al., Reference Horikawa, Oda, Cox, Li, Orho-Melander, Hara, Hinokio, Lindner, Mashima, Schwarz, del Bosque-Plata, Horikawa, Oda, Yoshiuchi, Colilla, Polonsky, Wei, Concannon, Iwasaki, Schulze, Baier, Bogardus, Groop, Boerwinkle, Hanis and Bell2000). SNP-19 significantly alters the insulin sensitivity index by synthesis of a mutant protein and/or altered transcriptional regulation, which could contribute to the diabetes risk (Raj & Ramteke, Reference Raj and Ramteke2012). Given the unclear role of CAPN10 in diabetes pathogenesis, defining whether SNP-19 modifies diabetes risk in other populations is of critical importance. We focussed our investigation on the possible association between SNP-19 polymorphism in the CAPN10 gene and T2D in 3 ethnic groups of North-West India (Brahmin, Bania and Jat Sikhs).

2. Materials and methods

(i) Study participants

In the present study, a total of 607 samples (103 T2D cases and 102 healthy controls) from the Brahmin community; (100 T2D cases and 100 healthy controls) from the Bania community and (100 T2D cases and 102 healthy controls) from Jat Sikhs of North-West Indian population were analysed. Diagnosis of T2D was made according to the criteria given by American Diabetes Association (2011). Informed consent as per Indian Council of Medical Research (ICMR) guidelines was obtained from all the studied subjects before withdrawing their blood samples and the study was approved by the institutional ethical committee. Sex and ethnicity matched individuals of 40 years of age or above without family history of diabetes were included as controls for the present study. Clinical and demographic details; and anthropometric measurements like height, weight, waist circumference (WC), hip circumference (HC) were measured.

(ii) Genotyping

SNP-19 is a biallelic insertion/deletion (I/D) polymorphism consisting of two or three copies of a 32-bp repeat sequence. Genomic DNA was extracted from peripheral blood by standard phenol–chloroform method (Gill et al., Reference Gill, Jeffreys and Werrett1985) with some modifications. This polymorphism was typed using primers as given by Evans et al. (Reference Evans, Frayling, Cassell, Saker, Hitman, Walker, Levy, O'Rahilly, Rao, Bennett, Jones, Menzel, Prestwich, Simecek, Wishart, Dhillon, Fletcher, Millward, Demaine, Wilkin, Horikawa, Cox, Bell, Ellard, McCarthy and Hattersley2001). The amplified PCR products were analysed by electrophoresis on 2·5% agarose gels. DNA bands were visualized by staining gel with ethidium bromide and photographed under UV transilluminator. Allele 1 (two repeats) is 155 bp, and allele 2 (three repeats) is 187 bp in length.

(iii) Statistical analysis

Continuous data is represented as mean±standard deviation (SD). Two-tailed Student's t-test was used to calculate the mean difference between the continuous variables. CaTS power calculator was used to determine the power of the study (Skol et al., Reference Skol, Scott, Abecasis and Boehnke2006). Hardy–Weinberg equilibrium (HWE) was tested in all ethnic groups using the chi-square test. Allele frequency in T2D cases and controls was calculated by the gene counting method and categorical variables were compared by the chi-square test. Statistical significance threshold was adopted to be <0·05. Association analysis between cases and controls was performed for genotype frequencies, allele frequencies and different genetic models using chi-square analysis. Odds ratio (OR) at 95% confidence interval (CI) was determined for alleles and genetic models. Corrections for age, sex, WC, waist–hip ratio (WHR) and body mass index (BMI) were also performed using Logistic regression. Hazard ratio (HR) obtained from Cox regression models with their corresponding CI towards T2D susceptibility on the basis of BMI according to CAPN10 SNP-19 genotypes was done. The statistical analysis was performed using Statistical Package for Social Science program (SPSS version 16.0; SPSS Chicago, IL).

The meta-analysis was carried out by using Comprehensive Meta-Analysis software (version 2). The HWE was tested for all studies included in the analysis. The statistical significance of summary OR was determined with Z-test and P < 0·05 was considered statistically significant. We also analysed different genetic models (dominant, recessive and codominant models) for the polymorphism under study in meta-analysis. Heterogeneity among studies was examined with the Q-test and I 2 statistics. If there was no significant heterogeneity, the fixed-effect model (the Mantel–Haenszel method) was employed to estimate the summary OR. Otherwise, the random-effect model (the DerSimonian and Laird method) was adopted. We also assessed the publication bias using Egger's regression asymmetry test with the significance level at 0·05 and funnel plot. Begg and Mazumdar test was performed to further assess the potential effects of publication bias. The analyses of these studies were chronologically ordered by publication year.

3. Results

The comparison of clinical parameters among T2D cases and controls in the three ethnic groups are given in Table 1. Significant differences were observed in age (P = 0·003) in Banias; age (P = 0·001) and WHR (P = 0·03) in Jat Sikhs after Bonferroni correction. Random blood sugar (RBS) was seen to be statistically significant in all three ethnic groups (P < 0·05). No other clinical parameter was found significant in the Brahmin group. The distribution of genotypes and allele frequencies of CAPN10 SNP-19 polymorphism among T2D cases and controls are summarized in Table 2. Power of the study was more than 85% for the pooled data and 65% for individual ethnic group. The genotype distribution in all the ethnic groups was in accordance with HWE. Significant association between the genotypic (P = 0·009) and allelic frequencies [OR = 1·73(0·87–3·43 at 95% CI), P = 0·006] were observed in Brahmins. However, no significant difference in genotype and allele frequencies was seen among Banias and Jat Sikhs. Analysis under dominant model (II versus ID+DD) revealed that II genotype provided approximately 3-fold risk towards T2D susceptibility [OR = 2·83 (1·43–5·61 at 95% CI), P = 0·003] in the Brahmin population after correction for age, sex, WC, WHR and BMI.

Table 1. Comparison of clinical parameters of cases and controls in 3 ethnic groups (Brahmins, Banias and Jat Sikhs) of North-West India

Data represented as mean±SD, *P value (after Bonferroni correction) <0·05 are considered to be significant. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; RBS, random blood sugar; WC, waist circumference.

Table 2. Allele frequency and genotypic model distribution of CAPN10 SNP19 I/D polymorphism and on the basis of BMI (⩾23·0) in T2D and Controls

*P<0·05 is significant, **P Corrected for Age, Sex, BMI, WC and WHR.

BMI was categorized on the basis of normal cut-off values recommended for the Asian Indians as described by Snehalatha et al. (Reference Snehalatha, Viswanathan and Ramachandran2003). Significant difference was observed in the distribution of CAPN10 SNP-19 genotype (P = 0·02) and allele frequency [OR = 1·88 (1·19–2·98 at 95% CI), P = 0·007] distribution of polymorphism in BMI ⩾ 23 in T2D cases and controls of Brahmins (Table 2). Further analysis of various genetic models in comparison between different groups revealed that under dominant model (II versus ID+DD), I allele increases the susceptibility towards T2D in individuals with higher BMI [OR = 3·31 (1·52–7·20 at 95% CI), P = 0·003] after correction for age, sex, WC, WHR and BMI. No significant difference was seen in Bania and Jat Sikh groups.

When BMI was examined as a continuous variable (Fig. 1), the risk towards T2D susceptibility with increase in BMI according to the genotypes was not significantly different in Bania (P = 0·31) and Jat Sikh (P = 0·72) groups, as similar trend were observed for II versus ID/DD genotype model in T2D. However, in Brahmins, II genotype tends to give nearly 1·5-fold more risk as compared to ID/DD genotype for T2D susceptibility with increase in BMI [OR = 1·47 (0·98–2·21 at 95% CI), P = 0·04].

Fig. 1. HR of T2D by BMI in (A) Brahmins (B) Banias and (C) Jat Sikhs stratified by CAPN10 II versus ID/DD model.

(i) Meta-analysis results

Literature search identified 117 studies related to the calpain-10 gene. Data from 13 articles that investigated the association between the CAPN10 I/D polymorphic variant and T2D met the inclusion criteria and were included in the meta-analysis. Total number of cases enrolled in these studies was 15 760 comprising of 8395 T2D cases and 7365 controls (Online Supplementary Table S1 at http://journals.cambridge.org/grh).

Figure 2 shows the results between CAPN10 I/D polymorphic variant and the risk of T2D. Lesser heterogeneity between studies was observed in overall analysis (P = 0·21, I 2 = 20·67%). Presence of I-allele in meta-analysis shows no association [fixed effect OR = 0·95 (0·88–1·01 at 95% CI), P = 0·09]. All studies are also suggesting the neutral effect of I-allele on T2D except two studies (Baroudi et al., Reference Baroudi, Corona, Skhiri, Ben, Abid and Elgaaied2009; Ezzidi et al., Reference Ezzidi, Turki, Messaoudi, Chaieb, Kacem, Al-Khateeb, Mahjoub, Almawi and Mtiraoui2010) providing protective role (P = 0·048 and P = 0·0005, respectively) whereas the present study on the Brahmin ethnic group conferred a significant risk for T2D [OR = 1·73 (0·87–3·43 at 95% CI), P = 0·006 (Supplementary Table S2 at http://journals.cambridge.org/grh). Under dominant model analysis (Fig. 3), carriers of I-allele is not suggestive of any conclusive role for T2D [random effect OR = 0·89 (0·77–1·02 at 95% CI), P = 0·10] with evidence of between study heterogeneity (P = 0·000, I 2 = 70·24%). Co-dominant model (Fig. 4) analysis gave a non-significant association [random effect OR = 1·04 (0·94–1·15 at 95% CI), P = 0·39; I 2 = 41·83%, P = 0·04]. However, recessive model (Fig. 5) DD carriers provided increased risk for T2D susceptibility [fixed effect OR = 1·09 (1·01–1·2 at 95% CI), P = 0·03; I 2 = 4·14%, P = 0·41] (Supplementary Table S3 at http://journals.cambridge.org/grh).

Fig. 2. Forest plot of OR estimates with corresponding 95% CI of the allele contrast (CAPN10 I versus D) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Fig. 3. Forest plot of OR estimates with corresponding 95% CI of the genotype model (CAPN10 II versus ID+DD) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Fig. 4. Forest plot of OR estimates with corresponding 95% CI of the genotype model (CAPN10 ID versus II+DD) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Fig. 5. Forest plot of OR estimates with corresponding 95% CI of the genotype model (CAPN10 DD versus II+ID) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

To assess the publication bias, we calculated the Egger's regression asymmetry tests which showed no evidence of publication bias in all three genetic models (dominant: P = 0·38; recessive: P = 0·81; and codominant: P = 0·26). Begg–Mazumdar test results suggested a low probability of publication bias in all genetic contrasts (dominant: P = 0·71; recessive: P = 0·90; and codominant: P = 0·65). No publication bias was seen on analysing the funnel plots for allelic contrasts (Fig. 6).

Fig. 6. Evaluation of publication bias using a funnel plot. No significant funnel asymmetry was observed which could indicate publication bias. The horizontal line in the funnel plot indicates the random effects summary estimate, while the sloping lines indicate the expected 95% CIs for a given standard error, assuming no heterogeneity between studies. Each circle represents a study.

4. Discussion

CAPN10 has been established as an important candidate gene for T2D susceptibility by positional cloning and variants in the gene have been associated with an increased risk of T2D in several populations (Horikawa et al., Reference Horikawa, Oda, Cox, Li, Orho-Melander, Hara, Hinokio, Lindner, Mashima, Schwarz, del Bosque-Plata, Horikawa, Oda, Yoshiuchi, Colilla, Polonsky, Wei, Concannon, Iwasaki, Schulze, Baier, Bogardus, Groop, Boerwinkle, Hanis and Bell2000; Tsuchiya et al., Reference Tsuchiya, Schwarz, Bosque-Plata, Geoffrey, Dina, Froguel, Wayne, Fischer, Temelkova-Kurktschiev, Rietzsch, Graessler, Vcelák, Palyzová, Selisko, Bendlová, Julius, Hanefeld, Weedon, Evans, Frayling, Hattersley, Orho-Melander, Groop, Malecki, Hansen, Pedersen, Fingerlin, Boehnke, Hanis, Cox and Bell2006; Adak et al., Reference Adak, Sengupta, Chowdhury and Bhattacharyya2010; Ezzidi et al., Reference Ezzidi, Turki, Messaoudi, Chaieb, Kacem, Al-Khateeb, Mahjoub, Almawi and Mtiraoui2010). SNP-19 polymorphism has been reported to influence insulin sensitivity and mRNA level of CAPN10 (Nakamura et al., Reference Nakamura, Koyama and Matsushima1998; Elbein et al., Reference Elbein, Chu, Ren, Hemphill, Schay, Cox, Hanis and Hasstedt2002). However, reports from Indian population give a heterogeneous picture owing to its diverse ethnicity. Therefore, we evaluated the relationship between CAPN10 SNP-19 and T2D in three ethnic groups of Punjab. To the best of our knowledge, association between CAPN10 SNP-19 polymorphism has not been reported yet in these endogamous groups of North-West India.

The distribution of ancestral I-allele of the studied polymorphism in controls varied from 0·55 to 0·69 (Supplementary Table S2 at http://journals.cambridge.org/grh). Frequency of I-allele is reported to be lesser in Brahmins (0·46) than rest of Asians (Cassell et al., Reference Cassell, Jackson, North, Evans, Syndercombe-Court, Phillips, Ramachandran, Snehalatha, Gelding, Vijayaravaghan, David Curtis and Hitman2002; Adak et al., Reference Adak, Sengupta, Chowdhury and Bhattacharyya2010; Bodhini et al., Reference Bodhini, Radha, Ghosh, Sanapala, Majumder, Rao and Mohana2011). The north-western Indian region has experienced several waves of immigrations like invasions from the Middle East and Central Asia which added to the complexity of genetic diversity (Mehra, Reference Mehra2010). Therefore, ethnic heterogeneity seems to play an important role in the distribution of allele frequency across different population groups.

Haplotype analysis of CAPN10 variants (SNP-43, -19 and -63) have implicated the role of SNP-19 II genotype towards increased risk of T2D in Tunisians (haplotype 121/221) [OR = 2·38 (1·05–5·48 at 95% CI), P = 0·02] and Polish populations (haplotype 121/121) [OR = 1·93 (1·03–3·54 at 95% CI), P = 0·03] (Malecki et al., Reference Malecki, Moczulski, Klupa, Wanic, Cyganek, Frey and Sieradzki2002; Kifagi et al., Reference Kifagi, Makni, Mnif, Boudawara, Hamza, Rekik, Abid, Rebaï, Granier, Jarraya and Ayadi2008). On the contrary, a study conducted on Tunisian Arab population supported the association of SNP-19 DD genotype with risk of T2D (Ezzidi et al., Reference Ezzidi, Turki, Messaoudi, Chaieb, Kacem, Al-Khateeb, Mahjoub, Almawi and Mtiraoui2010). Another study on Arabs and Berbers population suggested association of DD genotype with high risk of T2D in Arab sub-group only (Baroudi et al., Reference Baroudi, Corona, Skhiri, Ben, Abid and Elgaaied2009). Reports from South Indians (Cassell et al., Reference Cassell, Jackson, North, Evans, Syndercombe-Court, Phillips, Ramachandran, Snehalatha, Gelding, Vijayaravaghan, David Curtis and Hitman2002), Spanish (Saez et al., Reference Saez, Gonzalez-Sanchez, Ramirez-Lorca, Martínez-Larrad, Zabena, González, Morón, Ruiz and Serrano-Ríos2008), Asian (Song et al., Reference Song, You, Hsu, Sul, Wang, Tinker, Eaton and Liu2007) and Swedish (Einarsdottir et al., Reference Einarsdottir, Mayans, Ruikka, Escher, Lindgren, Agren, Eliasson and Holmberg2006) populations fail to support the association of this variant with T2D, which is in agreement with the results of present study observed for Bania and Jat Sikh groups. Obesity is considered as a key risk factor that has contributed to the rising prevalence of T2D (McCarthy, Reference McCarthy2010). Our results in the Brahmin group were in concordance with a study on Japanese population (Shima et al., Reference Shima, Nakanishi, Odawara, Kobayashi and Ohta2003), which also associated SNP-19 II genotype with increased BMI. The control population in the Bania and the Jat Sikh groups also presented with higher BMI owing to their sedentary lifestyle, higher energy intake and reduced energy expenditure (Kalra & Unnikrishnan, Reference Kalra and Unnikrishnan2012). Thus, the present study indicates the importance of different ethnic/endogamous groups in differential roles of genetic polymorphisms to disease susceptibility under the effect of different environmental conditions.

In the present study, the consistency of genetic effects of SNP19 I/D polymorphism across populations from different ethnicities was investigated through meta-analysis. No other meta-analysis has been done individually on this polymorphic variant till now. The overall results from the meta-analysis indicated that CAPN10 I allele is not associated with T2D while analysis under dominant and codominant models showed significant heterogeneity. The studied variant has been associated with either no significant effect or a protective role towards T2D in certain subgroups (Tunisian Arabs and Scandinavians) (Rasmussen et al., Reference Rasmussen, Urhammer, Berglund, Jensen, Hansen, Echwald, Borch-Johnsen, Horikawa, Mashima, Lithell, Cox, Hansen, Bell and Pedersen2002; Ezzidi et al., Reference Ezzidi, Turki, Messaoudi, Chaieb, Kacem, Al-Khateeb, Mahjoub, Almawi and Mtiraoui2010); but is associated with an increased risk in the Brahmin ethnic group in the present study. The power of individual studies is usually low which affects the rate of false discovery. Therefore, meta-analysis improves the power and reduces the rate of false discovery. The present meta-analysis supported an association of T2D with carriers of DD genotype of CAPN10 I/D polymorphism. However, SNP19 is an intronic variant with comparatively lesser functional implications. Therefore, further studies screening the role of functionally relevant variants in the promoter and coding regions of CAPN10 gene in linkage disequilibrium with SNP19 are required to be undertaken on a larger sample size to establish the effect of CAPN10 polymorphisms on the aetiology of the disease.

5. Conclusions

The present investigation suggests that II genotype in CAPN10 SNP-19 locus appears to increase the risk towards T2D susceptibility in Brahmins but not in Banias and Jat Sikhs suggesting population specific risk towards T2D. Comprehensive meta-analysis indicates that there is insufficient evidence to demonstrate a strong association between CAPN10 SNP-19 polymorphism and risk of T2D. However, there seems to be a significant association between DD genotype and T2D predisposition. The exact role of the variant still remained to be an unresolved issue. Therefore, further large scale, better designed population-based studies are needed to ascertain the impact of this variant on diabetes risk.

We would like to thank the patients and controls for taking part in this study.

Financial Support

The financial assistance to Sharma R by UGC is acknowledged. Financial support from DBT through project grant: BT/PR8846/MED/12/327/2007 (DBT, India) to Bhanwer AJS at Guru Nanak Dev University, Amritsar is also acknowledged.

Statement of Interest

None.

Ethical Standards

The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008.

Supplementary material

The online data can be found available at http://journals.cambridge.org/grh.

References

Adak, S., Sengupta, S., Chowdhury, S. & Bhattacharyya, M. (2010). Co-existence of risk and protective haplotypes of calpain 10 gene to type 2 diabetes in the eastern Indian population. Diabetes and Vascular Disease Research 7, 6368.CrossRefGoogle ScholarPubMed
AlSaraj, F., O'Gorman, D., McAteer, S., McDermott, J., Hawi, Z. & Sreenan, S. (2010). Haplotype association of calpain 10 gene variants with type 2 diabetes mellitus in an Irish sample. Irish Journal of Medical Sciences 179, 269272.CrossRefGoogle Scholar
American Diabetes Association (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care 34, S11S61.Google Scholar
Baroudi, T. O., Corona, J. S., Skhiri, H. A., Ben, M. H., Abid, H. K. & Elgaaied, A. B. (2009). Study of Association of the SNP19 polymorphism of calpain 10 gene with type 2 diabetes in ethnic sub-groups of the Tunisian population: gene-environment interaction. Annales de Biologie Clinique 67, 171176.Google Scholar
Bodhini, D., Radha, V., Ghosh, S., Sanapala, K. R., Majumder, P. P., Rao, M. R. S. & Mohana, V. (2011). Association of calpain 10 gene polymorphisms with type 2 diabetes mellitus in Southern Indians. Metabolism 60, 681688.Google ScholarPubMed
Cassell, P. G., Jackson, A. E., North, B. V., Evans, J. C., Syndercombe-Court, D., Phillips, C., Ramachandran, A., Snehalatha, C., Gelding, S. V., Vijayaravaghan, S., David Curtis, D. & Hitman, G. A. (2002). Haplotype combinations of calpain 10 gene polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in south Indians. Diabetes 51, 16221628.CrossRefGoogle ScholarPubMed
Chen, S. F., Lu, X. F., Yan, W. L., Huang, J. F. & Dong-feng, G. U. (2007). Variations in the calpain-10 gene are associated with the risk of type 2 diabetes and hypertension in northern Han Chinese population. Chinese Medical Journal 120, 22182223.CrossRefGoogle ScholarPubMed
Cox, N. J., Hayes, M. G., Roe, C. A., Tsuchiya, T. & Bell, G. I. (2004). Linkage of calpain 10 to type 2 diabetes: the biological rationale. Diabetes 53, S19S25.CrossRefGoogle ScholarPubMed
Einarsdottir, E., Mayans, S., Ruikka, K., Escher, S. A., Lindgren, P., Agren, A., Eliasson, M. & Holmberg, D. (2006). Linkage but not association of calpain-10 to type 2 diabetes replicated in northern Sweden. Diabetes 55, 18791883.CrossRefGoogle Scholar
Elbein, S. C., Chu, W., Ren, Q., Hemphill, C., Schay, J., Cox, N. J., Hanis, C. L. & Hasstedt, S. J. (2002). Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians. Journal of Clinical Endocrinology and Metabolism 87, 650654.CrossRefGoogle ScholarPubMed
Evans, J. C., Frayling, T. M., Cassell, P. G., Saker, P. J., Hitman, G. A., Walker, M., Levy, J. C., O'Rahilly, S., Rao, P. V. S., Bennett, A. J., Jones, E. C., Menzel, S., Prestwich, P., Simecek, N. K., Wishart, M., Dhillon, R., Fletcher, C., Millward, A., Demaine, A., Wilkin, T., Horikawa, Y., Cox, N. J., Bell, G. I., Ellard, S., McCarthy, M. I. & Hattersley, A. T. (2001). Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. American Journal of Human Genetics 69, 544552.CrossRefGoogle ScholarPubMed
Ezzidi, I., Turki, A., Messaoudi, S., Chaieb, M., Kacem, M., Al-Khateeb, G. M., Mahjoub, T., Almawi, W. Y. & Mtiraoui, N. (2010). Common polymorphisms of calpain-10 and the risk of type 2 diabetes in a Tunisian Arab population: a case-control study. BMC Medical Genetics 11, 75.CrossRefGoogle Scholar
Gill, P., Jeffreys, A. J. & Werrett, D. J. (1985). Forensic application of DNA fingerprints. Nature 318, 577579.CrossRefGoogle ScholarPubMed
Herder, C. & Roden, M. (2011). Genetics of type 2 diabetes: pathophysiologic and clinical relevance. European Journal of Clinical Investigation 41, 679692.CrossRefGoogle ScholarPubMed
Horikawa, Y., Oda, N., Cox, N. J., Li, X., Orho-Melander, M., Hara, M., Hinokio, Y., Lindner, T. H., Mashima, H., Schwarz, P. E., del Bosque-Plata, L., Horikawa, Y., Oda, Y., Yoshiuchi, I., Colilla, S., Polonsky, K. S., Wei, S., Concannon, P., Iwasaki, N., Schulze, J., Baier, L. J., Bogardus, C., Groop, L., Boerwinkle, E., Hanis, C. L. & Bell, G. I. (2000). Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nature Genetics 26, 163175.CrossRefGoogle ScholarPubMed
Horikawa, Y., Oda, N., Yu, L., Imamura, S., Fujiwara, K., Makino, M., Seino, Y., Itoh, M. & Takeda, J. (2003). Genetic variations in calpain-10 gene are not a major factor in the occurrence of type 2 diabetes in Japanese. Journal of Clinical Endocrinology and Metabolism 88, 244247.CrossRefGoogle ScholarPubMed
Hu, F. B. (2011). Prevention of diabetes and cardiovascular disease among prediabetic individuals: lifestyle versus drug interventions. European Journal of Cardiovascular Prevention and Rehabilitation 18, 810812.CrossRefGoogle ScholarPubMed
International Diabetes Federation (2011). IDF Diabetes Atlas, 5th edn. Brussels: International Diabetes Federation.Google Scholar
Iwasaki, N., Horikawa, Y., Tsuchiya, T., Kitamura, Y., Nakamura, T., Tanizawa, Y., Oka, Y., Hara, K., Kadowaki, T., Awata, T., Honda, M., Yamashita, K., Oda, N., Yu, L., Yamada, N., Ogata, M., Kamatani, N., Iwamoto, Y., Del Bosque-Plata, L., Hayes, M. G., Cox, N. J. & Bell, G. I. (2005). Genetic variants in the calpain-10 gene and the development of type 2 diabetes in the Japanese population. Journal of Human Genetics 50, 9298.CrossRefGoogle ScholarPubMed
Kalra, S. & Unnikrishnan, A. G. (2012). Obesity in India: the weight of the nation. Journal of Medical Nutrition and Nutraceuticals 1, 3741.CrossRefGoogle Scholar
Kang, E. S., Kim, H. J., Nam, M., Nam, C. M., Ahn, C. W., Cha, B. S. & Lee, H. C. (2006). A novel 111/121 diplotype in the calpain-10 gene is associated with type 2 diabetes. Journal of Human Genetics 51, 629633.CrossRefGoogle ScholarPubMed
Kifagi, C., Makni, K., Mnif, F., Boudawara, M., Hamza, N., Rekik, N., Abid, M., Rebaï, A., Granier, C., Jarraya, F. & Ayadi, H. (2008). Association of calpain-10 polymorphisms with type 2 diabetes in the Tunisian population. Diabetes and Metabolism 34, 273278.CrossRefGoogle ScholarPubMed
Malecki, M. T., Moczulski, D. K., Klupa, T., Wanic, K., Cyganek, K., Frey, J. & Sieradzki, J. (2002). Homozygous combination of calpain 10 gene haplotypes is associated with type 2 diabetes mellitus in a Polish population. European Journal of Endocrinology 146, 695699.CrossRefGoogle Scholar
Marshall, C., Hitman, G. A., Partridge, C. J., Clark, A., Ma, H., Shearer, T. R. & Turner, M. D. (2005). Evidence that an isoform of calpain-10 is a regulator of exocytosis in pancreatic-cells. Molecular Endocrinology 19, 213224.CrossRefGoogle Scholar
McCarthy, M. I. (2010). Genomics, type 2 diabetes, and obesity. New England Journal of Medicine 363, 24.CrossRefGoogle ScholarPubMed
Mehra, N. K. (2010). Defining genetic architecture of the populations in the Indian subcontinent: impact of human leukocyte antigen diversity studies. Indian Journal of Medical Research 16, 105107.Google ScholarPubMed
Nakamura, Y., Koyama, K. & Matsushima, M. (1998). VNTR (variable number of tandem repeat) sequences as transcriptional, translational, or functional regulators. Journal of Human Genetics 43, 149152.CrossRefGoogle ScholarPubMed
Orho-Melander, M., Klannemark, M., Svensson, M. K., Ridderstrale, M., Lindgren, C. M. & Groop, L. (2002). Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes 51, 26582664.CrossRefGoogle ScholarPubMed
Raj, R. & Ramteke, P. W. (2012). Polymorphisms of calpain 10 (Capn10) in type 2 diabetes mellitus – a review. International Journal of Scientific and Research Publications 2, 14.Google Scholar
Rasmussen, S. K., Urhammer, S. A., Berglund, L., Jensen, J. N., Hansen, L., Echwald, S. M., Borch-Johnsen, K., Horikawa, Y., Mashima, H., Lithell, H., Cox, N. J., Hansen, T., Bell, G. I. & Pedersen, O. (2002). Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1) and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians. Diabetes 51, 35613567.CrossRefGoogle ScholarPubMed
Saez, M. E., Gonzalez-Sanchez, J. L., Ramirez-Lorca, R., Martínez-Larrad, M. T., Zabena, C., González, A., Morón, F. J., Ruiz, A. & Serrano-Ríos, M. (2008). The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population. PLoS ONE 3, e2953.CrossRefGoogle ScholarPubMed
Shima, Y., Nakanishi, K., Odawara, M., Kobayashi, T. & Ohta, H. (2003). Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clinica Chimica Acta 336, 8996.CrossRefGoogle ScholarPubMed
Singh, S. (2011). Genetics of type 2 diabetes mellitus: a review. Journal of Scientometric Research 55, 3548.Google Scholar
Skol, A. D., Scott, L. J., Abecasis, G. R. & Boehnke, M. (2006). Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nature Genetics 38, 209213.CrossRefGoogle ScholarPubMed
Smith, L. K., Rice, K. M. & Garner, C. W. (1996). The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease. Molecular and Cellular Endocrinology 122, 8192.CrossRefGoogle ScholarPubMed
Snehalatha, C., Viswanathan, V. & Ramachandran, A. (2003). Cut off value for normal anthropometric variable in Asian Indian adults. Diabetes Care 26, 13801384.CrossRefGoogle Scholar
Song, Y., You, N. C., Hsu, Y. H., Sul, J., Wang, L., Tinker, L., Eaton, C. B. & Liu, S. (2007). Common genetic variation in calpain-10 gene (CAPN10) and diabetes risk in a multi-ethnic cohort of American postmenopausal women. Human Molecular Genetics 16, 29602971.CrossRefGoogle Scholar
Tsuchiya, T., Schwarz, P. E., Bosque-Plata, L. D., Geoffrey, H. M., Dina, C., Froguel, P., Wayne, T. G., Fischer, S., Temelkova-Kurktschiev, T., Rietzsch, H., Graessler, J., Vcelák, J., Palyzová, D., Selisko, T., Bendlová, B. J., Julius, U., Hanefeld, M., Weedon, M. N., Evans, J. C., Frayling, T. M., Hattersley, A. T., Orho-Melander, M., Groop, L., Malecki, M. T., Hansen, T., Pedersen, O., Fingerlin, T. E., Boehnke, M., Hanis, C. L., Cox, N. J. & Bell, G. I. (2006). Association of the calpain-10 gene with type 2 diabetes in Europeans: results of pooled and meta-analyses. Molecular Genetics and Metabolism 89, 174184.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Comparison of clinical parameters of cases and controls in 3 ethnic groups (Brahmins, Banias and Jat Sikhs) of North-West India

Figure 1

Table 2. Allele frequency and genotypic model distribution of CAPN10 SNP19 I/D polymorphism and on the basis of BMI (⩾23·0) in T2D and Controls

Figure 2

Fig. 1. HR of T2D by BMI in (A) Brahmins (B) Banias and (C) Jat Sikhs stratified by CAPN10 II versus ID/DD model.

Figure 3

Fig. 2. Forest plot of OR estimates with corresponding 95% CI of the allele contrast (CAPN10 I versus D) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Figure 4

Fig. 3. Forest plot of OR estimates with corresponding 95% CI of the genotype model (CAPN10 II versus ID+DD) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Figure 5

Fig. 4. Forest plot of OR estimates with corresponding 95% CI of the genotype model (CAPN10 ID versus II+DD) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Figure 6

Fig. 5. Forest plot of OR estimates with corresponding 95% CI of the genotype model (CAPN10 DD versus II+ID) and predisposition of T2D. The OR estimate of each study is marked with a symbol. The CIs are displayed as a horizontal line through the respective symbols. The horizontal axis is plotted on a log scale. ‘Baroudi 2009a and 2009b’ are Arabs and Berbers of Djerba Island, respectively; ‘Present study a, b and c’ are Brahmin, Bania and Jat Sikh groups of the present study.

Figure 7

Fig. 6. Evaluation of publication bias using a funnel plot. No significant funnel asymmetry was observed which could indicate publication bias. The horizontal line in the funnel plot indicates the random effects summary estimate, while the sloping lines indicate the expected 95% CIs for a given standard error, assuming no heterogeneity between studies. Each circle represents a study.

Supplementary material: File

Sharma Supplementary Material

Table S1

Download Sharma Supplementary Material(File)
File 15.8 KB
Supplementary material: File

Sharma Supplementary Material

Table S2

Download Sharma Supplementary Material(File)
File 15.5 KB
Supplementary material: File

Sharma Supplementary Material

Table S3

Download Sharma Supplementary Material(File)
File 14.9 KB